Syros Pharmaceuticals

Pfizer to end license deal with Syros for blood disorder therapies
Reuters
Mon, 07/24/23 - 09:48 pm
Pfizer
Syros Pharmaceuticals
sickle cell disease
beta thalassemia
Two cancer biotechs merge, raise cash as sector-wide downturn continues
BioPharma Dive
Tue, 07/5/22 - 11:45 pm
Syros Pharmaceuticals
Tyme Technologies
M&A
cancer
oncology
ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise
Fierce Biotech
Mon, 09/20/21 - 12:00 pm
ESMO
Syros Pharmaceuticals
breast cancer
Pfizer
Ibrance
ESMO 2021 – the jury remains out on CDK7 inhibition
EP Vantage
Fri, 09/17/21 - 11:02 am
ESMO
Syros Pharmaceuticals
Carrick Therapeutics
breast cancer
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Motley Fool
Sun, 02/23/20 - 06:17 pm
beta thalassemia
rare disease
drug development
Acceleron
Bristol-Myers Squibb
Bluebird Bio
Sangamo Therapeutics
Vertex Pharmaceuticals
Editas Medicine
Syros Pharmaceuticals
Here's Why Syros Pharmaceuticals Is Collapsing Today
Motley Fool
Fri, 04/5/19 - 11:35 pm
Syros Pharmaceuticals
JPM18: Incyte and Syros to collaborate in cancer R&D
Biopharma Dive
Wed, 01/10/18 - 06:57 pm
Incyte
Syros Pharmaceuticals
cancer
R&D
JPMHC 2018
Despite sluggish IPO market, biotechs continue to lead the way
BioPharma Dive
Wed, 07/6/16 - 11:11 am
IPOs
biotech
Reata Pharmaceuticals
Syros Pharmaceuticals
The 2015 Fierce 15 biotech execs take a bow
Fierce Biotech
Sat, 10/3/15 - 02:01 pm
Alector
Arvinas
CRISPR Therapeutics
Intellia Therapeutics
NGM Biopharmaceuticals
Padlock Therapeutics
SQZ Biotech
Revolution Medicines
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
FierceBiotech's 2015 Fierce 15
Fierce Biotech
Wed, 09/30/15 - 09:51 am
Alector
Arvinas
Cell Medica
CRISPR Therapeutics
Denali Therapeutics
Intellia Therapeutics
MyoKardia
NGM Biopharmaceuticals
Padlock Therapeutics
Revolution Medicines SQZ Biotech
Surface Oncology
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics